The development of minimally invasive cardiac patches, either as hemostatic dressing or
treating myocardial infarction, is of clinical significance but remains a major challenge …

The convergence of tissue engineering and patient-specific stem cell biology has enabled
the engineering of in vitro tissue models that allow the study of patient-tailored treatment …

Tissue engineering has markedly matured since its early beginnings in the 1980s. In
addition to the original goal to regenerate damaged organs, the field has started to explore …

Advances in material science and innovative medical technologies have allowed the
development of less invasive interventional procedures for deploying implant devices …

A myocardial infarction (MI) is the leading cause of morbidity and mortality, seriously
threatens human health, and becomes a major health burden of our society. It is urgent to …

Endothelial cells (ECs) are critical for several aspects of cardiovascular disease therapy,
including vascular regeneration, personalized drug development, and tissue engineering …

Cardiovascular disease is the number one killer worldwide, with myocardial infarction (MI)
responsible for approximately 1 in 6 deaths. The lack of endogenous regenerative capacity …

Hydrogels have emerged in various biomedical applications, including tissue engineering
and medical devices, due to their ability to imitate the natural extracellular matrix (ECM) of …

Low circulating levels of insulin-like growth factor 1 (IGF-1) have been correlated with an
increased risk for cardiovascular diseases in humans. In this work, an injectable alginate …

Ischemic diseases including myocardial infarction (MI) and limb ischemia are some of the
greatest causes of morbidity and mortality worldwide. Cell therapy is a potential treatment …